The Lp(a) of 220 that explained why a 'healthy' 36-year-old ended up in the ER

Three weeks before

I had been to my annual physical three weeks before. The note in the portal had said the same thing it always said. All values within normal limits. Continue current routine.

My LDL was 110. My HDL was 55. My triglycerides were a clean 90. My fasting glucose was 88. My blood pressure had been 118 over 76 for the better part of a decade. My doctor had clicked through the panel on her screen and said, Good news, see you next year. I had said the same thing back to her in the same easy tone.

I was 36. I ran four times a week, ate the way most people who think about it casually eat, did not smoke, drank moderately. The panel had been clean for five years running. There was, by every metric available to me, no story here.

The Tuesday in March

The Tuesday in March started ordinarily. Halfway through my usual walk to lunch I felt something tighten across my chest in a way I had not felt before, and I assumed it was the pressed sandwich from the day before catching up with me late. I sat on a bench for twenty minutes thinking it would pass.

It got worse. It moved into my left arm, which is the one phrase from every cardiac diagram I had ever seen, and which I refused to think about for another fifteen minutes because it could not, given everything I knew about myself, be that.

My wife drove me to the ER because I was embarrassed to call 911. The troponin was elevated. There was a partial blockage in one of three coronary arteries. A stent was placed that evening. I was discharged thirty-six hours later, holding a printed discharge summary in a hospital gown in a parking lot, 36 years old.

The follow-up that changed everything

Two weeks after discharge I sat in a cardiologist's office for the first time in my life. He had read the chart, the catheterization report, my prior labs. He looked up.

A 36-year-old with a clean lipid panel does not normally end up where you ended up, he said. I want to add a few tests your primary doesn't usually order.

Among them were Lp(a) and ApoB. The blood was drawn that afternoon. The results came back the following Tuesday.

Lp(a): 220 nmol/L. The reference range topped out at 75.

The cardiologist explained it slowly. This is genetic. You inherited this. None of your previous panels would have caught it, because none of them were looking for it.

I sat with the sentence for a while. The panel had been fine because the panel had not been looking. The number that explained the Tuesday in March had been sitting in my blood since the day I was born, and nobody — including me — had ever asked it a question.

What Lp(a) actually is

What I had not understood, before, was that Lp(a) is a particle built like LDL — a cholesterol-carrying core wrapped in a particular protein — but with one extra piece attached, an additional protein called apolipoprotein(a). The extra piece is what makes it a different metric, and what makes it dangerous in a way that ordinary LDL is not.

Levels are largely set by genetics. Diet barely moves them. Exercise barely moves them. Most of the things that move LDL — fiber, saturated fat, weight loss, statins — move Lp(a) very little or not at all. About one in five adults has elevated Lp(a). Most do not know.

It is not on a standard lipid panel. It has to be specifically ordered. Two people with the same LDL can have very different cardiovascular trajectories over thirty years if their Lp(a) numbers differ by a factor of five.

There is also this: Lp(a) is essentially measured once in a lifetime. The number does not change much. The number you have at thirty is essentially the number you will have at sixty. AHA and European cardiology guidelines have begun to add it to recommended once-in-life screening, recently and quietly, the way large recommendations sometimes change.

The family history I hadn't connected

My grandfather had died of old age at 56, which is the kind of thing the family said in the 1980s about deaths nobody had wanted to call by their actual name. My uncle had a heart thing at 48 and survived. My father had had indigestion at 50, which had turned out to be the kind of indigestion that requires admission to a hospital.

None of these had been connected in my head, until they were. They had been three different events at three different funerals and one different hospital, told in three different decades, and they had never sat next to one another long enough for the pattern to be obvious.

Lp(a) had been moving through my family for at least three generations, quietly, the way a thing moves when nobody is looking for it. My older brother got tested after my event and came back elevated. My younger brother got tested and came back clean. My nephew, when he is old enough, will be tested too. The chart has more lines on it now than it had before.

What changed after the diagnosis

I am now on appropriate medications under my cardiologist's guidance. I will not get into the specifics of which ones or at what doses. That part is between me and my cardiologist, and the right answer for one person is rarely the right answer for another with a different chart.

What I will say is the shape of the strategy. The goal of the management is to lower the things that are modifiable, hard, so that the thing that is not — the Lp(a) — does less of its work over the next thirty years. My LDL is now driven well below 110, lower than the panel had ever called fine. My ApoB is monitored alongside, because particle count tells a different part of the story than cholesterol concentration alone.

The honest part: the Lp(a) itself has not moved. There are not great tools for that yet, despite what some corners of the wellness internet sometimes suggest. New therapies are in trial that may change this in five or ten years. For now, the strategy is to attack the parts of the equation that can be attacked, and to leave the part that cannot be attacked under careful watch.

I am not less likely to have a second event because of who I am. I am less likely because of what I now know.

Where the chart is now

It is November, three years past the Tuesday in March. Annual cardiac follow-up. Numbers stable. I run again, slightly slower than before, and I have stopped expecting chest tightness in the same way you stop expecting a sound after a long time without hearing it.

The Lp(a) had been tracking through my family for three generations. The test costs about thirty dollars. I am not sure why it was not on a standard panel until last year, but I am very sure it should have been on mine.